20051209
 Eli Lilly & Co.: New-Product Sales May Help '06 Profit to Surpass Estimates   The Wall Street Journal,  Dec 10, 2005  Eli Lilly & Co. said it expects 2006 earnings to exceed Wall Street's expectations, helped by new-product sales and stabilized U.S. sales of its Zyprexa antipsychotic drug, which had been losing market share amid concerns it can cause weight gain and diabetes.   
